Agenda Cancer Care Symposium 2023

Day One: General Oncology Nursing

7 a.m.

Registration, Breakfast & View Exhibits

7:50 a.m.

Welcome & Morning Announcements

Laura Lettkeman, MBA, BSN, RN

8 a.m.

ECANA: Endometrial Cancer Action Network for African-Americans

Shawn Smith

9 a.m.

Fertility Sparing Options for Gynecological Cancers

Jo Marie Janco, MD

10 a.m.

Break & View Exhibits

10:30 a.m.

Colorectal Cancer: Updates in Current Screening Guidelines and Treatment

Jason Willis, MD

11:30 a.m.

Recent Advances in Therapy for Renal and Bladder Cancer

Munveer Bhangoo, MD

12:30 p.m.

Lunch Break

12:30-1:30 p.m.

Non-CE Lunch Symposium Hosted by Exelixis

An Exelixis Product for the Clinical Management of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma

Suresh Ratnam, MD, FACP

1:30 p.m.

Palliative Care in Cancer

Kathryn Hughlock, DNP, AGNP-C, ACHPN

2:30 p.m.

Plastic Surgery for Cancer Patients: A Comprehensive Review

Crystal tenCate, RN, MS, FNP-C, APRN, CPSN

3:30 p.m.

Break & View Exhibits

3:45 p.m.

The Power of Mentorship in Leading Change

Deena O’Shea, RN, MSN, OCN, NE-BC

4:45 p.m.

Adjourn

5-6 p.m.

Non-CE Dinner Symposium Hosted by Takeda Oncology

ALUNBRIG (brigatinib) for the First-Line Treatment of ALK+mNSCLC – Clinical Case Study: Cindy

Arya Amini, MD

Day Two: Advanced Practice Oncology

7-7:50 a.m.

Non-CE Breakfast Symposium Hosted by Pfizer

A Treatment Option for Relapsed or Refractory Multiple Myeloma

Josh Epworth, NP

7 a.m.

Breakfast & View Exhibits

7:50 a.m.

Welcome & Morning Announcements

Joanna Wood, MSN, RN, OCN, BMTCN

8 a.m.

Post COVID Implications for Oncology Patients

Amy Spallone, MD

9 a.m.

What’s New: Oncology Drug Updates Part 1

Matt Fox, PharmD, BCPS, BCOP

10 a.m.

Break & View Exhibits

10:30 a.m.

What’s New: Oncology Drug Updates Part 2

Bryan Do, PharmD, BCOP

11:30 a.m.

Navigating Insurance Challenges in Cancer Care

Sarah Bottomley, DNP, APRN, CPNP

12:30 p.m.

Lunch

12:30-1:30 p.m.

Non-CE Lunch Symposium Hosted by Seagen

PADCEV (enfortumab vedotin-ejfv): Use in Combination With a PD-1 Inhibitor

Nazy Zomorodian, MSN, CUNP

1:30 p.m.

Cracking the Code: How Genetics Plays a Role in Cancer Risk, Treatment and Outcomes

Jennifer Siettmann, MS, CGC

2:30 p.m.

Cancer in the Transgender and Gender-Diverse Population

Daniel Arellano, PhD, APRN, ACNP-BC, CCRN, FCCM, FAANP

3:30 p.m.

Break & View Exhibits

3:45 p.m.

Breakthroughs in Multiple Myeloma Treatment

Rebecca Lu, MSN, RN, FNP-BC

4:45 p.m.

Closing Remarks and Final Adjournment

**Topics, speakers, and order of talks subject to change